Exclusive eBook: How AI is becoming the next military advisor

A collection of stories about how militaries are using AI models to make decisions. This subscriber-only eBook is a package of six stories that were originally published in MIT Technology Review between April 11, 2025, and April 21, 2026, and have been updated to reflect recent developments. by James O’Donnell Choose which file format to…

16 June 2026

The Download: the first brain implant power user and South Korea’s AI obsession

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. This man with ALS is the first “power user” of a brain implant that lets him speak Casey Harrell has had a set of electrodes embedded in his brain for almost…

16 June 2026

Want to get a data center online quickly? Give it some flex.

At the end of a tense and scoreless first half of a soccer match between the English men’s team and rival Germany, millions of Brits let out a collective sigh and did what they so often do in moments of stress: They made tea. That wave of electric kettles clicking on, however, caused a different…

16 June 2026

Why do South Koreans love AI so much?

This story originally appeared in The Algorithm, our weekly newsletter on AI. To get stories like this in your inbox first, sign up here. When I landed in Seoul after a grueling 12-hour flight from San Francisco, I walked through an unmanned immigration checkpoint, where a machine scanned my face and passport. On the subway home,…

15 June 2026

This man with ALS is “the first power user” of a brain implant that lets him speak

Casey Harrell has had a set of electrodes embedded in his brain for almost three years. Harrell, who has amyotrophic lateral sclerosis (ALS) and is paralyzed, first used his brain-computer interface (BCI) to “speak” sentences with the help of a research team in 2023. Since then, Harrell has clocked thousands of hours of use. He…

15 June 2026

The Download: cutting AC emissions, and nature’s drug designer

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. These new solid-state ACs promise a cool future. Scientists aren’t so sure. After three years of record-­breaking heat and another scorcher underway, air-conditioning isn’t going anywhere. That’s good for our health,…

15 June 2026

These new solid-state ACs promise a cool future. Scientists aren’t so sure.

After three years of record-­breaking heat, this one is set to be yet another scorcher. Air-conditioning? Not going anywhere. The International Energy Agency projects that the number of AC units will triple by 2050. That’s good for health—one Lancet study estimated that AC prevented nearly 200,000 premature deaths in 2019 alone—but bad for the planet.…

15 June 2026

The Download: “reprogramming” aging, and the hidden sense of interoception

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology. Why “reprogramming” is the buzziest approach to reversing aging right now Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first…

12 June 2026

You do your own time

There we were, a regular murderers’ row of librarians. Little Jo. Eustace. And me. Turning around in the nave of our library to greet the sound of footsteps, pistols leveled in case whoever was coming in didn’t respect sanctuary. Little Jo had a stack of books under one arm. Eustace was holding the screwdriver she’d…

12 June 2026

Why “reprogramming” is the buzziest approach to reversing aging right now

Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…

12 June 2026